Hmdb loader
Survey
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 17:48:11 UTC
Update Date2021-09-26 23:13:16 UTC
HMDB IDHMDB0257116
Secondary Accession NumbersNone
Metabolite Identification
Common NameRazaxaban
DescriptionN-(4-{2-[(dimethylamino)methyl]-1H-imidazol-1-yl}-2-fluorophenyl)-1-(3-imino-2,3-dihydro-1,2-benzoxazol-5-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboximidic acid belongs to the class of organic compounds known as aromatic anilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with an aromatic group. They have the general structure RNC(=O)R', where R= benzene, and R = aryl group. Based on a literature review very few articles have been published on N-(4-{2-[(dimethylamino)methyl]-1H-imidazol-1-yl}-2-fluorophenyl)-1-(3-imino-2,3-dihydro-1,2-benzoxazol-5-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboximidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). Razaxaban is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Razaxaban is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
N-(4-{2-[(dimethylamino)methyl]-1H-imidazol-1-yl}-2-fluorophenyl)-1-(3-imino-2,3-dihydro-1,2-benzoxazol-5-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboximidateGenerator
BMS-5613RAZAXABANChEMBL
1-(3'-Aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-(2-fluoro-4-((2'-dimethylaminomethyl)imidazol-1-yl)phenyl)-1H-pyrazole-5-carboxamide hydrochlorideMeSH
DPC-906MeSH
Razaxaban hydrochlorideMeSH
1-(3'-Aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-(2-fluoro-4-((2'-dimethylaminomethyl)imidazol-1-yl)phenyl)-1H-pyrazole-5-carboxamideMeSH
DPC 906MeSH
Chemical FormulaC24H20F4N8O2
Average Molecular Weight528.4616
Monoisotopic Molecular Weight528.164534744
IUPAC NameN-(4-{2-[(dimethylamino)methyl]-1H-imidazol-1-yl}-2-fluorophenyl)-1-(3-imino-2,3-dihydro-1,2-benzoxazol-5-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboximidic acid
Traditional NameN-(4-{2-[(dimethylamino)methyl]imidazol-1-yl}-2-fluorophenyl)-2-(3-imino-2H-1,2-benzoxazol-5-yl)-5-(trifluoromethyl)pyrazole-3-carboximidic acid
CAS Registry NumberNot Available
SMILES
CN(C)CC1=NC=CN1C1=CC(F)=C(C=C1)N=C(O)C1=CC(=NN1C1=CC2=C(ONC2=N)C=C1)C(F)(F)F
InChI Identifier
InChI=1S/C24H20F4N8O2/c1-34(2)12-21-30-7-8-35(21)13-3-5-17(16(25)10-13)31-23(37)18-11-20(24(26,27)28)32-36(18)14-4-6-19-15(9-14)22(29)33-38-19/h3-11H,12H2,1-2H3,(H2,29,33)(H,31,37)
InChI KeyOFJRNBWSFXEHSA-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as aromatic anilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with an aromatic group. They have the general structure RNC(=O)R', where R= benzene, and R = aryl group.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassAnilides
Direct ParentAromatic anilides
Alternative Parents
Substituents
  • Aromatic anilide
  • 1-phenylimidazole
  • Benzisoxazole
  • 2-heteroaryl carboxamide
  • Pyrazole-5-carboxamide
  • Halobenzene
  • Fluorobenzene
  • Aralkylamine
  • N-substituted imidazole
  • Aryl fluoride
  • Aryl halide
  • Imidolactam
  • Isoxazole
  • Azole
  • Imidazole
  • Pyrazole
  • Heteroaromatic compound
  • Secondary carboxylic acid amide
  • Tertiary amine
  • Tertiary aliphatic amine
  • Amino acid or derivatives
  • Carboxamide group
  • Oxacycle
  • Carboxylic acid derivative
  • Azacycle
  • Organoheterocyclic compound
  • Primary amine
  • Organic nitrogen compound
  • Amine
  • Alkyl halide
  • Alkyl fluoride
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organic oxygen compound
  • Organooxygen compound
  • Organonitrogen compound
  • Organohalogen compound
  • Organofluoride
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.56ALOGPS
logP2.35ChemAxon
logS-4.3ALOGPS
pKa (Strongest Acidic)5.84ChemAxon
pKa (Strongest Basic)7.16ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area116.58 ŲChemAxon
Rotatable Bond Count7ChemAxon
Refractivity164.35 m³·mol⁻¹ChemAxon
Polarizability49.29 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+210.05430932474
DeepCCS[M-H]-207.65830932474
DeepCCS[M-2H]-240.69330932474
DeepCCS[M+Na]+215.96630932474
AllCCS[M+H]+218.832859911
AllCCS[M+H-H2O]+217.132859911
AllCCS[M+NH4]+220.432859911
AllCCS[M+Na]+220.832859911
AllCCS[M-H]-209.932859911
AllCCS[M+Na-2H]-210.032859911
AllCCS[M+HCOO]-210.332859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
RazaxabanCN(C)CC1=NC=CN1C1=CC(F)=C(C=C1)N=C(O)C1=CC(=NN1C1=CC2=C(ONC2=N)C=C1)C(F)(F)F4269.4Standard polar33892256
RazaxabanCN(C)CC1=NC=CN1C1=CC(F)=C(C=C1)N=C(O)C1=CC(=NN1C1=CC2=C(ONC2=N)C=C1)C(F)(F)F4349.0Standard non polar33892256
RazaxabanCN(C)CC1=NC=CN1C1=CC(F)=C(C=C1)N=C(O)C1=CC(=NN1C1=CC2=C(ONC2=N)C=C1)C(F)(F)F3859.9Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Razaxaban,2TMS,isomer #1CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C)C(=N)C3=C2)C(F)=C13895.0Semi standard non polar33892256
Razaxaban,2TMS,isomer #1CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C)C(=N)C3=C2)C(F)=C13863.7Standard non polar33892256
Razaxaban,2TMS,isomer #1CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C)C(=N)C3=C2)C(F)=C14875.1Standard polar33892256
Razaxaban,2TMS,isomer #2CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3O[NH]C(=N[Si](C)(C)C)C3=C2)C(F)=C13763.4Semi standard non polar33892256
Razaxaban,2TMS,isomer #2CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3O[NH]C(=N[Si](C)(C)C)C3=C2)C(F)=C14029.9Standard non polar33892256
Razaxaban,2TMS,isomer #2CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3O[NH]C(=N[Si](C)(C)C)C3=C2)C(F)=C14884.3Standard polar33892256
Razaxaban,2TMS,isomer #3CN(C)CC1=NC=CN1C1=CC=C(N=C(O)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C)C(=N[Si](C)(C)C)C3=C2)C(F)=C13907.2Semi standard non polar33892256
Razaxaban,2TMS,isomer #3CN(C)CC1=NC=CN1C1=CC=C(N=C(O)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C)C(=N[Si](C)(C)C)C3=C2)C(F)=C14034.2Standard non polar33892256
Razaxaban,2TMS,isomer #3CN(C)CC1=NC=CN1C1=CC=C(N=C(O)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C)C(=N[Si](C)(C)C)C3=C2)C(F)=C14797.4Standard polar33892256
Razaxaban,3TMS,isomer #1CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C)C(=N[Si](C)(C)C)C3=C2)C(F)=C13850.3Semi standard non polar33892256
Razaxaban,3TMS,isomer #1CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C)C(=N[Si](C)(C)C)C3=C2)C(F)=C13971.4Standard non polar33892256
Razaxaban,3TMS,isomer #1CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C)C(=N[Si](C)(C)C)C3=C2)C(F)=C14535.4Standard polar33892256
Razaxaban,2TBDMS,isomer #1CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C(C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C(C)(C)C)C(=N)C3=C2)C(F)=C14211.0Semi standard non polar33892256
Razaxaban,2TBDMS,isomer #1CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C(C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C(C)(C)C)C(=N)C3=C2)C(F)=C14243.0Standard non polar33892256
Razaxaban,2TBDMS,isomer #1CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C(C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C(C)(C)C)C(=N)C3=C2)C(F)=C14851.5Standard polar33892256
Razaxaban,2TBDMS,isomer #2CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C(C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3O[NH]C(=N[Si](C)(C)C(C)(C)C)C3=C2)C(F)=C14093.4Semi standard non polar33892256
Razaxaban,2TBDMS,isomer #2CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C(C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3O[NH]C(=N[Si](C)(C)C(C)(C)C)C3=C2)C(F)=C14413.1Standard non polar33892256
Razaxaban,2TBDMS,isomer #2CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C(C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3O[NH]C(=N[Si](C)(C)C(C)(C)C)C3=C2)C(F)=C14920.0Standard polar33892256
Razaxaban,2TBDMS,isomer #3CN(C)CC1=NC=CN1C1=CC=C(N=C(O)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C(C)(C)C)C(=N[Si](C)(C)C(C)(C)C)C3=C2)C(F)=C14238.2Semi standard non polar33892256
Razaxaban,2TBDMS,isomer #3CN(C)CC1=NC=CN1C1=CC=C(N=C(O)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C(C)(C)C)C(=N[Si](C)(C)C(C)(C)C)C3=C2)C(F)=C14421.7Standard non polar33892256
Razaxaban,2TBDMS,isomer #3CN(C)CC1=NC=CN1C1=CC=C(N=C(O)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C(C)(C)C)C(=N[Si](C)(C)C(C)(C)C)C3=C2)C(F)=C14837.8Standard polar33892256
Razaxaban,3TBDMS,isomer #1CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C(C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C(C)(C)C)C(=N[Si](C)(C)C(C)(C)C)C3=C2)C(F)=C14321.7Semi standard non polar33892256
Razaxaban,3TBDMS,isomer #1CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C(C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C(C)(C)C)C(=N[Si](C)(C)C(C)(C)C)C3=C2)C(F)=C14501.8Standard non polar33892256
Razaxaban,3TBDMS,isomer #1CN(C)CC1=NC=CN1C1=CC=C(N=C(O[Si](C)(C)C(C)(C)C)C2=CC(C(F)(F)F)=NN2C2=CC=C3ON([Si](C)(C)C(C)(C)C)C(=N[Si](C)(C)C(C)(C)C)C3=C2)C(F)=C14659.8Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Razaxaban GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Razaxaban GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Razaxaban GC-MS (TMS_1_3) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Razaxaban GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Razaxaban GC-MS (TBDMS_1_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Razaxaban GC-MS (TBDMS_1_3) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID176799
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]